Drug Discovery Featured Articles & Applications
-
Understanding The Impact Of An RMP On Patient Risks Using Relational Risk Analysis
5/5/2025
Using relational risk analysis, let's take a closer look at risk management plans for identifying and managing adverse reactions for administering a new therapy to a patient.
-
Designing The Next Wave Of T Cell Engagers
5/1/2025
Abpro's associate director of biology has led programs in immuno-oncology R&D with a focus on therapeutic T cell engagers. We caught up with him to discuss how industry can pave a future for the field.
-
AI Vs. Humans In Novel Drug Target Identification
4/30/2025
Artificial intelligence is beginning to replace humans in drug discovery, one expert warns — but the industry isn’t ready for the shift.
-
A Checklist For Mechanism-Based Potency Testing In Cell Therapy
4/25/2025
New research concludes that potency cannot be decoupled from a product's mechanism of action because surrogate markers fail to capture functional relevance.
-
FDA RIFs Might Delay Your Review — Here Are Tips For Mitigating
4/24/2025
Mounting concerns that FDA reviewers could start missing PDUFA deadlines have put many on edge. The moment calls for defensive and offensive strategies.
-
Promising Clinical Trial Updates Shared At The American Academy Of Neurology Conference
4/24/2025
The 2025 American Academy of Neurology (AAN) conference in early April saw some promising clinical trial updates treating Guillain-Barre Syndrome and Huntington’s Disease, CIDP, and ALS.
-
How To Approach Tech Transfers And Sponsored Life Sciences Research In An AI Age
3/27/2025
Two IP attorneys examine the patentability of AI-conceived inventions and share tips for technology transfers and sponsored research in pharma/biotech.
-
Applying AI To Identify Synergistic Drug Combinations For Cancer Treatment
3/14/2025
By combining drugs/therapies with different mechanisms of action, different pathways in cancer cells can be targeted, potentially leading to improved patient outcomes. Using AI is hastening this research.
-
Mesenchymal Stem Cells Hold The Key To Treating Degenerative Conditions
3/7/2025
Mesenchymal stem cells offer a promising path forward in managing complex conditions that are often age-related. What makes MSCs unique and how do they compare to iPSCs?
-
Understanding The New U.K. MHRA 'Draft Guideline On Individualised mRNA Cancer Immunotherapies'
3/5/2025
The U.K.'s MHRA has released a new draft guideline outlining best practices for drug product design, CMC, and manufacturing of mRNA cancer immunotherapies using LNP delivery systems. The public comment period ends March 31.